Low-dose nitrite alleviates early effects of an X-ray contrast medium on renal hemodynamics and oxygenation in rats

Investigative Radiology

Volumn 49, Issue 2, 2014, Pages 70-77

  Seeliger, Erdmann ^a   Cantow, Kathleen ^a   Arakelyan, Karen ^a,b   Ladwig, Mechthild ^a   Persson, Pontus B ^a   Flemming, Bert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Contrast induced nephropathy; Nitrite; Renal hemodynamics; Renal oxygenation

Indexed keywords

IODIXANOL; METHEMOGLOBIN; NITRITE; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BOLUS INJECTION; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ERYTHROCYTE; HEMOGLOBIN BLOOD LEVEL; KIDNEY BLOOD FLOW; KIDNEY PARENCHYMA; LOW DRUG DOSE; MALE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; TISSUE OXYGENATION; TREATMENT RESPONSE; VASOCONSTRICTION; VASODILATATION;

ACUTE KIDNEY INJURY; ANIMALS; BLOOD FLOW VELOCITY; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; MALE; NITRITES; OXYGEN; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; RENAL CIRCULATION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIIODOBENZOIC ACIDS;

EID: 84893685470     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182a6fea6     Document Type: Article

References (49)

1. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol. 2010;6:679-688.
2. Bagshaw SM, Culleton BF. Contrast-induced nephropathy: epidemiology and prevention. Minerva Cardioangiol. 2006;54:109-129.
3. James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37-43.
4. Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010;122:2451-2455.
5. Seeliger E, Sendeski M, Rihal CS, et al. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J. 2012;33:2007-2015.
6. Evans RG, Ince C, Joles JA, et al. Haemodynamic influences on kidney oxygenation: the clinical implications of integrative physiology. Clin Exp Pharmacol Physiol. 2013;40:106-122.
7. Heyman SN, Rosen S, Khamaisi M, et al. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45: 188-195.
8. Liss P, Nygren A, Erikson U, et al. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int. 1998;53: 698-702.
9. Seeliger E, Flemming B, Wronski T, et al. Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol. 2007;18:2912-2920.
10. Hofmann L, Simon-Zoula S, Nowak A, et al. BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int. 2006;70:144-150.
11. Haneder S, Augustin J, Jost G, et al. Impact of iso- and low-osmolar iodinated contrast agents on BOLD and diffusion MRI in swine kidneys. Invest Radiol. 2012;47:299-305.
12. Li LP, Franklin T, Du H, et al. Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose. J Magn Reson Imaging. 2012;36:1162-1167.
13. Lenhard DC, Frisk AL, Lengsfeld P, et al. The effect of iodinated contrast agent properties on renal kinetics and oxygenation. Invest Radiol. 2013;48: 175-182.
14. Arakelyan K, Cantow K, Hentschel J, et al. Early effects of an x-ray contrast medium on renal T2/T2 MRI as compared to short-term hyperoxia, hypoxia and aortic occlusion in rats. Acta Physiol (Oxf ). 2013;208:202-213.
15. Sendeski MM, Bondke PA, Liu ZZ, et al. Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta. Am J Physiol Renal Physiol. 2012;303:F1592-F1598.
16. Moody WE, Edwards NC, Madhani M, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis. 2012;223:86-94.
17. Popolo A, Autore G, Pinto A, et al. Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radic Res. 2013;47: 346-356.
18. Gladwin MT, Grubina R, Doyle MP. The new chemical biology of nitrite reactions with hemoglobin: R-state catalysis, oxidative denitrosylation, and nitrite reductase/anhydrase. Acc Chem Res. 2009;42:157-167.
19. Parthasarathy DK, Bryan NS. Sodium nitrite: the "cure" for nitric oxide insufficiency. Meat Sci. 2012;92:274-279.
20. Zweier JL, Li H, Samouilov A, et al. Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall. Nitric Oxide. 2010;22:83-90.
21. Calvert JW, Lefer DJ. Clinical translation of nitrite therapy for cardiovascular diseases. Nitric Oxide. 2010;22:91-97.
22. Tripatara P, Patel NS, Webb A, et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol. 2007;18:570-580.
23. Milsom AB, Patel NS, Mazzon E, et al. Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice. Nitric Oxide. 2010;22:141-148.
24. Kelpke SS, Chen B, Bradley KM, et al. Sodium nitrite protects against kidney injury induced by brain death and improves post-transplant function. Kidney Int. 2012;82:304-313.
25. Seeliger E, Ladwig M, Sargsyan L, et al. Proof of principle: hydration by lowosmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats. Invest Radiol. 2012;47:240-246.
26. Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol. 2000;27:313-319.
27. Pluta RM, Oldfield EH, Bakhtian KD, et al. Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS ONE. 2011; 6:e14504.
28. Evans RG, Gardiner BS, Smith DW, et al. Methods for studying the physiology of kidney oxygenation. Clin Exp Pharmacol Physiol. 2008;35:1405-1412.
29. Pohlmann A, Cantow K, Hentschel J, et al. Linking non-invasive parametric MRI with invasive physiological measurements (MR-PHYSIOL): towards a hybrid and integrated approach for investigation of acute kidney injury in rats. Acta Physiol (Oxf ). 2013;207:673-689.
30. Zhang Y,Wang J, Yang X, et al. The serial effect of iodinated contrast media on renal hemodynamics and oxygenation as evaluated by ASL and BOLD MRI. Contrast Media Mol Imaging. 2012;7:418-425.
31. Myers SI, Wang L, Liu F, et al. Iodinated contrast induced renal vasoconstriction is due in part to the downregulation of renal cortical and medullary nitric oxide synthesis. J Vasc Surg. 2006;44:383-391.
32. Ladwig M, Flemming B, Seeliger E, et al. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats. Invest Radiol. 2011;46:672-677.
33. Seeliger E, Becker K, Ladwig M, et al. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat. Radiology. 2010;256:406-414.
34. Ueda J, Nygren A, Hansell P, et al. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol. 1993;34:83-87.
35. Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol. 1995;6:1451-1458.
36. Kim SJ, Salem MR, Joseph NJ, et al. Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg. 1990;71:73-76.
37. Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527-2540.
38. Dejam A, Hunter CJ, Tremonti C, et al. Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation. 2007;116:1821-1831.
39. Maher AR, Milsom AB, Gunaruwan P, et al. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation. 2008;117:670-677.
40. Dezfulian C, Alekseyenko A, Dave KR, et al. Nitrite therapy is neuroprotective and safe in cardiac arrest survivors. Nitric Oxide. 2012;26:241-250.
41. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009;90:1-10.
42. Okamoto M, Tsuchiya K, Kanematsu Y, et al. Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in kidney. Am J Physiol Renal Physiol. 2005;288:F182-F187.
43. Hamburger T, Broecker-Preuss M, Hartmann M, et al. Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats. J Surg Res. 2013;183:e7-e21.
44. Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9: 1498-1505.
45. Ingram TE, Pinder AG, Bailey DM, et al. Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means which is not dependent upon a simultaneous elevation in plasma nitrite. Am J Physiol Heart Circ Physiol. 2009;298:H331-H339.
46. Greenway FL, Predmore BL, Flanagan DR, et al. Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients. Diabetes Technol Ther. 2012;14:552-560.
47. Ingram TE, Fraser AG, Bleasdale RA, et al. Low-dose sodium nitrite attenuates myocardial ischemia and vascular ischemia-reperfusion injury in human models. J Am Coll Cardiol. 2013;61:2534-2541.
48. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA. 2011;306:53-61.
49. Lenhard DC, Pietsch H, Sieber MA, et al. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. Invest Radiol. 2012; 47:503-510.